Laser treatment for chronic central serous chorioretinopathy
Part of Eyes & vision clinical trials.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with central serous chorioretinopathy (fluid buildup under the retina) that did not improve after 6 months of treatment with two specific medications (Acetazolamide and Eplerenone).
- The fluid under the center of your retina has been present for at least 6 months.
- You are 18 years or older and can read and understand the informed consent form.
- You have not had any other retinal treatments for this condition besides the two medications mentioned.
- You do not have other eye diseases such as age-related macular degeneration, diabetic retinopathy, or abnormal blood vessels in the eye.
- You do not have severe nearsightedness or farsightedness (more than 6 diopters) or uncontrolled glaucoma requiring eyedrops.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for chronic central serous chorioretinopathy (CSC), a condition that causes fluid buildup under the retina. It tests whether adding a light therapy (photodynamic therapy) to micropulse laser treatment helps improve vision more than laser alone.
This trial tests a low-energy “subthreshold” laser to treat long-lasting fluid under the retina from central serous chorioretinopathy (CSCR). It may help dry up the fluid and improve vision, compared with a sham (placebo) treatment.
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This study is testing whether mindfulness-based stress reduction can help people with central serous chorioretinopathy (CSCR), a condition causing fluid buildup under the retina. If you have active CSCR that started recently, you might be eligible.
This trial tests whether taking oral melatonin (a natural hormone) can help treat central serous chorioretinopathy, a condition where fluid builds up under the retina and blurs vision. It may be a good fit if you were recently diagnosed and haven't had certain eye procedures recently.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.